Wells Fargo & Company Wave Life Sciences Ltd. Transaction History
Wells Fargo & Company
- $468 Billion
- Q2 2025
A detailed history of Wells Fargo & Company transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 124,667 shares of WVE stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,667
Previous 222,962
44.09%
Holding current value
$1.05 Million
Previous $1.8 Million
55.02%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding WVE
# of Institutions
191Shares Held
132MCall Options Held
551KPut Options Held
47.1K-
Ra Capital Management, L.P. Boston, MA18.2MShares$154 Million2.59% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA15MShares$127 Million0.17% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$69.8 Million0.92% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$56.9 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.53MShares$55.2 Million0.41% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $734M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...